New cellular immunotherapy approach shows promise for B-cell lymphoma (IMAGE)
Caption
A phase 1 clinical trial co-led by researchers at WashU Medicine found that a new type of cell-based immunotherapy was safe for patients with several types of B-cell lymphoma, a type of blood cancer. Larger studies are needed to assess efficacy, but the approach shows promise. Pictured is lead author, Armin Ghobadi, MD, of WashU Medicine, speaking with one of his patients. The patient, who was treated for a blood cancer at Siteman Cancer Center, was not involved in this clinical trial.
Credit
Matt Miller
Usage Restrictions
None
License
Original content